Tracey O’Brien: Read Karen’s powerful story
Tracey O’Brien shared a post on Linkedin:
“As Deputy CEO of ACON, Karen Price embodies an unwavering commitment to championing the health and wellbeing of people of diverse sexualities and genders. The collaborative alliance with Karen and the ACON team is of paramount importance to Cancer Institute NSW and highlights the profound strength that arises when dedicated advocates join forces for a shared cause.
Cancer screening is life-saving, but it can be a confronting experience for some, including Karen.
Across NSW, we know there are many people who face barriers to cancer screening, including cervical screening.
While clinicians take great care performing the test, cervical screening can feel invasive and uncomfortable. That’s why the new self-collection option to the test is helping break down barriers, driving more people to own their screening experience and reduce their cervical cancer risk.
I’d like to thank Karen for bravely sharing her personal story and for highlighting that despite the challenges, there are options available to make screening that little bit easier.”
Read Karen’s powerful story here.
Source: Tracey O’Brien/LinkedIn
Dr. Tracey O’Brien is the NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, Australia. Before her current role, Tracey was Director of the Kids Cancer Centre, Sydney Children’s Hospital, and Director of the Transplant & Cellular Therapy Program. Tracey has held numerous high-profile national and international leadership positions, including Advisory Chair, Cancer Australia; V/Chair (Africa, Asia and Australasia) International Centre for Bone Marrow Transplant Research and V/President of the Australian and New Zealand Children’s Oncology Group. In recognition of her exceptional contributions, Tracey was profiled in 2023 as one of the world’s foremost women in paediatric cancer by the International Society of Paediatric Oncology. In 2019 Tracey was named in the Australian Financial Review’s prestigious Top 10 Women of Influence, winning the Innovation category. In addition to her medical expertise, Tracey has a Master of Law (Health) and executive MBA and serves as a conjoint Professor in Clinical Medicine (UNSW) and Honorary Professor in Science and Engineering (Macquarie University). Dr. O’Brien remains committed to mentoring the next generation of clinician leaders and maintains an active clinical practice in cancer survivorship at Sydney Children’s Hospital.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023